AUC	area under the plasma concentration—time curve
AUCinf	area under the plasma concentration—time curve from dosing to infinity
AUClast	area under the plasma concentration—time curve from dosing to the time of the last measured plasma concentration
Cmax	maximal plasma concentration
Ct	trough plasma concentration
C12	plasma concentration at 12 h after administration
C24	plasma concentration at 24 h after administration
tmax	time to maximal plasma concentration
t 1/2	elimination half-life
S.D.	standard deviation
C.V.	coefficient of variation
AE	adverse event
mCRPC	metastatic castration resistant prostate cancer
mCSPC	metastatic castration sensitive prostate cancer
FDA	Food and Drug Administration
PSA	prostate specific antigen
PFS	progression free survival
SGF	simulated gastric fluid
FaSSIF	fasted state simulated intestinal fluid
ECG	electrocardiogram
QD	once daily
GMR	geometric mean ratio
LC	liquid chromatography
MS	mass spectrometry
TOS	tablet for oral suspension
R-AA	reference abiraterone acetate